June 27, 2017 10:50 PM ET

Healthcare Equipment and Supplies

Company Overview of RareCyte, Inc.

Company Overview

RareCyte, Inc. develops diagnostic products for detection of rare cellular events, including circulating tumor cells. The company was founded in 2009 and is based in Issaquah, Washington.

1040 12th Avenue Northwest

Issaquah, WA 98027

United States

Founded in 2009

Phone:

425-557-1000

Key Executives for RareCyte, Inc.

Chairman, Chief Executive Officer and President
Vice President of Business Development and Finance
Compensation as of Fiscal Year 2016.

RareCyte, Inc. Key Developments

RareCyte Appoints Frank Witney to its Oard of Directors

RareCyte reported that Frank Witney has joined its board of directors. Most recently, Dr. Witney served as President and CEO of Affymetrix (now part of Thermo Fisher Scientific). Previously, Dr. Witney was President and CEO of Dionex. Prior to that, Dr. Witney first joined Affymetrix when it acquired Panomics which he led as President and CEO. Dr. Witney also served as President of PerkinElmer's Drug Discovery Tools division following the acquisition of Packard BioScience in 2001, where he served as President and COO. Dr. Witney also held several leadership positions at Bio-Rad Laboratories.

RareCyte, Inc. Appoints Frank Witney to its Board of Directors

RareCyte, Inc. announced that Frank Witney has joined its board of directors. Most recently, Dr. Witney served as President and CEO of Affymetrix, Inc.

RareCyte Partners with Leica Biosystems Nussloch GmbH to Co-Market RareCyte's Product Line

Leica Biosystems Nussloch GmbH and RareCyte, Inc. have announced the co-marketing of RareCyte's AccuCyte(R) CyteFinder(R) rare cell analysis product line with Leica Biosystems' BOND RX research staining platform.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact RareCyte, Inc., please visit www.rarecyte.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.